The Journal of Immunology, Vol 147, Issue 4 1230-1237, Copyright © 1991 by American Association of Immunologists

ARTICLES

Lymphotoxin and an associated 33-kDa glycoprotein are expressed on the surface of an activated human T cell hybridoma

JL Browning, MJ Androlewicz and CF Ware
Department of Cell Biology, Biogen Inc., Cambridge, MA 02142.

A human T cell hybridoma, II-23.D7, was induced with phorbol ester to express a surface form of lymphotoxin (LT, TNF-beta) and an associated 33-kDa glycoprotein. The LT epitopes were detected by surface immunofluorescence staining and by immunoprecipitation from radioiodinated or biosynthetically labeled cells with the use of anti- rLT polyclonal and monoclonal antibodies. The epitopes detected by the antibody were related to LT because adsorption of the anti-rLT with PMA- activated II-23.D7 cells resulted in the removal of the neutralizing titer of the anti-rLT antiserum. Immunoprecipitation of surface radioiodinated II-23.D7 cells revealed two bands of 25 kDa and 33 kDa that were specifically precipitated with anti-rLT, but not anti-rTNF antibodies. Enzymatic digestion with glycanases showed both proteins to have N-linked carbohydrate, with O-linked sugar limited to the 25-kDa protein. To determine the biochemical relationship between these proteins, the two LT-like forms were purified from detergent- solubilized II-23.D7 cells by immunoaffinity chromatography. Peptide mapping using CNBr cleavage showed the 25-kDa surface form to be identical to rLT, whereas the 33-kDa protein was different. Biosynthetic labeling studies showed that p33 contained both methionine and cysteine, whereas the p25 contained only methionine. Thus, the surface LT form lacks a leader peptide indicating an anchoring mechanism distinct from that described for membrane TNF. The nature of the attachment of this LT form to the membrane surface is not clear, however, neither TNF receptor binding nor lipid linkages appear to be involved. The accessory protein, p33, may anchor LT to the surface. These findings identify a new characteristic of LT and point toward an additional pathway by which T lymphocytes may mediate cytolytic activity and regulate inflammatory processes.

This article has been cited by other articles:

				D. C. Voon, L. S. Subrata, M. Karimi, D. Ulgiati, and L. J. Abraham TNF and Phorbol Esters Induce Lymphotoxin-{beta} Expression through Distinct Pathways Involving Ets and NF-{kappa}B Family Members J. Immunol., April 1, 2004; 172(7): 4332 - 4341. [Abstract] [Full Text] [PDF]

				H. Ohminami, M. Yasukawa, S. Kaneko, Y. Yakushijin, Y. Abe, Y. Kasahara, Y. Ishida, and S. Fujita Fas-Independent and Nonapoptotic Cytotoxicity Mediated by a Human CD4+ T-Cell Clone Directed Against an Acute Myelogenous Leukemia-Associated DEK-CAN Fusion Peptide Blood, February 1, 1999; 93(3): 925 - 935. [Abstract] [Full Text] [PDF]

				O. Hultgren, H.-P. Eugster, J. D. Sedgwick, H. Korner, and A. Tarkowski TNF/Lymphotoxin-{alpha} Double-Mutant Mice Resist Septic Arthritis but Display Increased Mortality in Response to Staphylococcus aureus J. Immunol., December 1, 1998; 161(11): 5937 - 5942. [Abstract] [Full Text] [PDF]

				J. R. Orlinick, K. B. Elkon, and M. V. Chao Separate Domains of the Human Fas Ligand Dictate Self-association and Receptor Binding J. Biol. Chem., December 19, 1997; 272(51): 32221 - 32229. [Abstract] [Full Text] [PDF]

				Y. Chicheportiche, P. R. Bourdon, H. Xu, Y.-M. Hsu, H. Scott, C. Hession, I. Garcia, and J. L. Browning TWEAK, a New Secreted Ligand in the Tumor Necrosis Factor Family That Weakly Induces Apoptosis J. Biol. Chem., December 19, 1997; 272(51): 32401 - 32410. [Abstract] [Full Text] [PDF]

				L. Williams-Abbott, B. N. Walter, T. C. Cheung, C. R. Goh, A. G. Porter, and C. F. Ware The Lymphotoxin-alpha (LTalpha ) Subunit Is Essential for the Assembly, but Not for the Receptor Specificity, of the Membrane-anchored LTalpha 1beta 2 Heterotrimeric Ligand J. Biol. Chem., August 1, 1997; 272(31): 19451 - 19456. [Abstract] [Full Text] [PDF]

				M.-Y. Wu, T.-L. Hsu, W.-W. Lin, R. D. Campbell, and S.-L. Hsieh Serine/Threonine Kinase Activity Associated with the Cytoplasmic Domain of the Lymphotoxin-beta Receptor in HepG2 Cells J. Biol. Chem., July 4, 1997; 272(27): 17154 - 17159. [Abstract] [Full Text] [PDF]

				M. Nishimura, S. Uchida, S. Mitsunaga, Y. Yahagi, K. Nakajima, K. Tadokoro, and T. Juji Characterization of T-Cell Clones Derived From Peripheral Blood Lymphocytes of a Patient With Transfusion-Associated Graft-Versus-Host Disease: Fas-Mediated Killing by CD4+ and CD8+ Cytotoxic T-Cell Clones and Tumor Necrosis Factor beta  Production by CD4+ T-Cell Clones Blood, February 15, 1997; 89(4): 1440 - 1445. [Abstract] [Full Text] [PDF]

				J. L. Browning, K. Miatkowski, D. A. Griffiths, P. R. Bourdon, C. Hession, C. M. Ambrose, and W. Meier Preparation and Characterization of Soluble Recombinant Heterotrimeric Complexes of Human Lymphotoxins alpha and beta J. Biol. Chem., April 12, 1996; 271(15): 8618 - 8626. [Abstract] [Full Text] [PDF]

				P. Crowe, T. VanArsdale, B. Walter, C. Ware, C Hession, B Ehrenfels, J. Browning, W. Din, R. Goodwin, and C. Smith A lymphotoxin-beta-specific receptor Science, April 29, 1994; 264(5159): 707 - 710. [Abstract] [PDF]